Zobrazeno 1 - 8 of 8 pro vyhledávání: '"Mph Millie D. Long Md"'
1
DOP25 Medication use and comorbidities among elderly when compared with younger patients with inflammatory bowel disease in the TARGET-IBD cohort
Autor: Corey A. Siegel, Miguel Regueiro, Julie M. Crawford, Edward L. Barnes, Derek Gazis, Marla Dubinsky, Bruce E. Sands, David T. Rubin, Mph Millie D. Long Md, J Hanson, Sumona Saha
Publikováno v: Journal of Crohn's and Colitis. 14:S063-S066
Background When compared with younger patients, much less is known regarding inflammatory bowel disease (IBD)-related medications in the elderly (>65 years) patients. This analysis uses a large cohort of patients with IBD to describe the distribution
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::4b249b8bc3944067c923fd1d52ea1545
https://doi.org/10.1093/ecco-jcc/jjz203.064
Zobrazit plný text záznamu
2
P778 Longitudinal trajectory of fatigue in inflammatory bowel disease patients: a prospective study
Autor: N. Borren, J. van der Woude, Mph Millie D. Long Md, Ashwin N. Ananthakrishnan, Robert S. Sandler
Publikováno v: Journal of Crohn's and Colitis. 14:S616-S617
Background Fatigue is a commonly reported and sometimes disabling symptom in patients with inflammatory bowel disease (IBD). Its prevalence, mechanism, and impact remain poorly understood. Using a large cohort of patients with IBD, we aimed to prospe
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::b49922cddccb1cec5778e97857348813
https://doi.org/10.1093/ecco-jcc/jjz203.906
Zobrazit plný text záznamu
3
P428 Oral mesalamine use in Crohn’s disease after implementation of the American College of Gastroenterology guidelines: a TARGET-IBD cohort study
Autor: M Weiss, Mph Millie D. Long Md, David T. Rubin, Stephanie Watkins, J Hanson, Nitin Gupta, Faten Aberra, Marla Dubinsky, Derek Gazis, Bruce E. Sands, Miguel Regueiro
Publikováno v: Journal of Crohn's and Colitis. 14:S389-S390
Background American College of Gastroenterology (ACG) guidelines for the management of adults with Crohn’s disease (CD) in March 2018 state that oral mesalamine, ‘should not be used…to treat CD.’ 1 This abstract estimates the prevalence of an
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::28bafb6e74850ef62c23f174d84f4cd5
https://doi.org/10.1093/ecco-jcc/jjz203.557
Zobrazit plný text záznamu
6
Narcotic use for inflammatory bowel disease and risk factors during hospitalization
Autor: Mph Millie D. Long Md, Hans H Herfarth, Edward L. Barnes, Douglas A. Drossman
Publikováno v: Inflammatory Bowel Diseases. 18:869-876
Growing evidence demonstrates the adverse effects of narcotics in inflammatory bowel disease (IBD). We sought to study the relationship between narcotic use, objective measures of disease activity, and other associated factors in hospitalized patient
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cbca2f1fa172b3852d51d8bc953ced7a
https://doi.org/10.1002/ibd.21806
Zobrazit plný text záznamu
7
Nonmelanoma skin cancer in inflammatory bowel disease
Autor: M Kappelman, Clare A. Pipkin, Mph Millie D. Long Md
Publikováno v: Inflammatory Bowel Diseases. 17:1423-1427
At least 1 million new cases of non-melanoma skin cancer (NMSC) are diagnosed in the United States each year, and the incidence is increasing. A higher incidence of non-melanoma skin cancer (NMSC) in organ transplant recipients on immunosuppression h
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::374a02ed7fb358208991767e481a1457
https://doi.org/10.1002/ibd.21484
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje